ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 073,98
0,57%
Dow Jones
41 841,63
0,85%
DAX
23 154,57
0,94%
Brent Oil
70,735
0,11%
Bitcoin
83 976,03
-0,10%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Magenta Therapeutics Inc (MGTA)

  7. Magenta Therapeutics Inc (MGTA) Actualités

MGTA

Magenta Therapeutics (MGTA)

Magenta Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MGTA
DateHeureSourceTitreSymboleSociété
16/09/202422h10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
16/09/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
13/09/202402h45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
08/08/202422h26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGTAMagenta Therapeutics Inc
08/08/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGTAMagenta Therapeutics Inc
29/05/202402h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202422h10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202422h09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MGTAMagenta Therapeutics Inc
11/04/202422h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGTAMagenta Therapeutics Inc
02/04/202400h34Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
28/03/202405h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGTAMagenta Therapeutics Inc
21/03/202422h02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
21/03/202421h07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MGTAMagenta Therapeutics Inc
14/02/202422h16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
02/02/202422h32Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGTAMagenta Therapeutics Inc
31/01/202418h11Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:MGTAMagenta Therapeutics Inc
04/10/202322h20Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MGTAMagenta Therapeutics Inc
21/09/202303h50Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
14/09/202303h31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
31/08/202315h00Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:MGTAMagenta Therapeutics Inc
17/07/202315h30Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
22/06/202323h25Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MGTAMagenta Therapeutics Inc
19/05/202322h28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MGTAMagenta Therapeutics Inc
19/05/202322h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202323h03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202322h13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MGTAMagenta Therapeutics Inc
15/05/202314h43Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MGTAMagenta Therapeutics Inc
03/05/202314h00Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:MGTAMagenta Therapeutics Inc
03/05/202313h00GlobeNewswire Inc.Magenta Therapeutics and Dianthus Therapeutics Announce Merger AgreementNASDAQ:MGTAMagenta Therapeutics Inc
01/05/202314h31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:MGTAMagenta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MGTA

Dernières Valeurs Consultées

COIN
IYFUSD
IYF.finance
AMEX
MUSQ
MUSQ Global Music Indust...
NYSE
BXMT
Blackstone Mortgage
USOTC
CLRMF
Clean Air Metals (QB)
BIT
S27191
Societe Generale Effekten
USOTC
CHKKF
Chakana Copper (QB)
USOTC
ACEEU
Ace Ethanal (GM)
USOTC
BDGSF
Bank of GA (PK)
NASDAQ
WWD
Woodward
AMEX
ICAP
Infracap Equity Income F...
UPBT
IOPBTC
Internet of People
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces